Evidence map›Paper›PMID 42519489›Full record

ArticleFrontiers in bioinformatics2026

A realistic simulation-based benchmark of microbiome normalization in sample stratification and taxa-level analysis.

Amen Al Khafaji, Daniel Vallejo-España, Carolina Gómez-Llorente, José Camacho

Abstract read
In one paragraph

Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amen Al KhafajiResearch Centre for Information and Communication Technologies (CITIC-UGR), University of Granada, Granada, Spain.
Daniel Vallejo-EspañaResearch Centre for Information and Communication Technologies (CITIC-UGR), University of Granada, Granada, Spain.
Carolina Gómez-LlorenteDepartment of Biochemistry and Molecular Biology II, School of Pharmacy, Institute of Nutrition and Food Technology José Mataix, Biomedical Research Center, University of Granada, Granada, Spain.
José CamachoResearch Centre for Information and Communication Technologies (CITIC-UGR), University of Granada, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Normalization is a critical step in microbiome studies because sequencing depth and sparsity can strongly affect downstream analyses. In real datasets, however, the underlying biological signal is unknown, making it difficult to determine whether a normalization method preserves true group differences or introduces distortions. To address this problem in a way that remains relevant to real applications, we developed a simulation-based evaluation framework informed by real microbiome data. The framework generates realistic datasets with known ground truth and enables quantitative comparison of normalization methods at both the sample and taxa levels. Results: Method performance depended on taxonomic resolution and on whether sequencing depth was confounded with group structure. In our case study, model-based normalization-factor methods, particularly edgeR-TMM and, in some settings, DESeq2, gave the closest match to the simulated biological contrast, indicating better recovery of taxa-level differences while preserving sample-level separation. TSS and rarefaction were often the next-best performers. Shannon diversity analyses further showed that sequencing-depth differences alone could create false-positive group differences for several methods, whereas rarefaction remained closest to nominal Type I error control. These results also showed that visual or statistical sample separation alone was not sufficient to judge normalization performance, because apparent group differences did not always correspond to correct taxa-level recovery. Rather than identifying a universally best method, the proposed framework provides a coherent strategy for evaluating existing and new normalization approaches under realistic, data-dependent scenarios.

Indexed as

metagenomicsmicrobiomenormalizationobservation-based missing data methods for exploratory data analysisprincipal component analysissequencing depth

Identifiers

PMID42519489
PMCPMC13381433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.